MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
Simmen HP et al. | [Erythromycin]. | 1982 | Dtsch. Med. Wochenschr. | pmid:7117164 |
Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
Trujillo H | Cefadroxil monohydrate versus erythromycin in paediatric patients. | 1981 | J. Int. Med. Res. | pmid:7227625 |
Abernathy CO et al. | Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note. | 1980 | Mech. Ageing Dev. | pmid:7354660 |
Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |
DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
Potthast H et al. | [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]. | 1995 | Pharmazie | pmid:7886126 |
Ginsburg CM et al. | Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions. | 1976 | J. Pediatr. | pmid:792404 |
Thibault N et al. | Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets. | 1993 | J. Hepatol. | pmid:8151096 |
Snellman LW et al. | Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. | 1993 | Pediatrics | pmid:8502522 |
Adam D and Scholz H | Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. | 1996 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8922570 |
Howard JE et al. | Otitis media of infancy and early childhood. A double-blind study of four treatment regimens. | 1976 | Am. J. Dis. Child. | pmid:8980 |
Halperin SA et al. | Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. | 1997 | Pediatrics | pmid:9200361 |
Venkateswaran S et al. | Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats. | 1997 | J Ethnopharmacol | pmid:9292408 |
Koranyi KI et al. | Evaluation of bacitracin ointment in the treatment of impetigo. | 1976 | Ohio State Med J | pmid:958658 |
Scholz H and Noack R | Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9764549 |